A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China
Condition: Tuberculosis, Multidrug-Resistant Interventions: Drug: Bedaquiline; Drug: Levofloxacin; Drug: Linezolid; Drug: Cycloserine; Drug: Clofazimine; Drug: Pyrazinamide; Drug: Protionamide Sponsor: Beijing Chest Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bedaquiline | China Health | Hospitals | Levaquin | Linezolid | Multidrug Resistance | Research | Study | Tuberculosis | Zyvox